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Abstract. [Purpose] The aim of this study was to determine whether physiotherapists (PT) scores are consistent 
over time when using Action Research Arm Test (ARAT) to assess upper limb (UL) function on a videotaped 
chronic stroke patient. [Participants and Methods] Quantitative correlational study. A convenience-snowball sam-
ple of 20 international PT (mean age and experience=32 ± 6.8 and 7.55 ± 7.4 years) used ARAT to score chronic 
stroke patient’s UL function, observing a video at baseline and again ≈ 2 weeks later. Two sets of non-parametric 
ordinal data were assessed with Spearman’s (rho) and the alpha (a) value was set at 0.01. Line of equality, Bland-
Altman plots and Wilcoxon signed rank test were also considered. [Results] Spearman’s rho was found ≈ 0.78 at a 
significance level of 0.00. ARAT was scored with a mean difference of 16.6 days and a mean change of 0.6 points 
was observed. Limits of agreement and coefficient of reproducibility were ± 2.3 and ± 2.6 respectively. The patient’s 
arm impairment was categorised as moderate and floor or ceiling effects were not detected. [Conclusion] The results 
suggest that ARAT is consistent, valid and should be used by PT in chronic stroke.
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INTRODUCTION
Stroke is a leading cause of disability or death, consisting of progressive neurological signs of cerebral dysfunction that 
last 24 hours, with a prevalent cause being of vascular origin1). While stroke mortality in UK accounts for 71 people per 
100,000, the incidence rate is 150/100,0002, 3), contributing to high costs to the NHS, with a total estimated cost of £9 billion 
annually for care4). After stroke, modifications in cortical representation due to spontaneous recovery and neuroplasticity 
occur over time5). Furthermore, 60% of survivors have impaired manual dexterity six months post-stroke and remain unable 
to perform arm-hand movements6–9). Dexterity reflect peoples’ performance in activities of daily living (ADL) and the aim 
of stroke rehabilitation is regaining upper limb (UL) function6–11).
Determining efficacy of treatments accurately and in a reproducible manner is crucial, thus clinicians remain concerned 
about the selection criteria of the most repeatable scale and its psychometric properties12, 13). Furthermore, measuring UL’s 
impairment in chronic stroke is essential for rehabilitation12, 13), and several outcome measures (OM) have been discussed 
with regard to the level of disability and relevance to UL progress14–24). OM with good psychometric properties and feasible 
administration time conducted by appropriately trained staff are recommended for stroke by national clinical guidelines25); 
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however, recommendations for tools or specific raters are not provided. The Action Research Arm Test (ARAT)14–17, 19, 20–24) 
is one of the most commonly used tools to capture change in hemiplegia. ARAT measures the ability to handle and move 
qualitatively either large or small objects regarding dexterity and proximal strength for both UL. KNGF (royal Dutch society 
of physiotherapists) clinical guidelines26) recommend ARAT to be applied by physiotherapists (PT) for UL examination in 
chronic stroke; however, EBRSR (evidence-based review of stroke rehabilitation)27) and ASA (American stroke associa-
tion)28) clinical guidelines do not clarify who can use it and report significant floor and ceiling effects. Prior studies have 
reported the reliability and validity of ARAT to be high14–17, 19, 21–24).
ARAT18) is based on the upper extremity function test (UEFT)16), which comprises four subscales: grasp, grip, pinch, and 
gross. Lyle16) eliminated items that were inconsistent, reducing the time required to complete the test by 50% for patients with 
chronic hemiparesis (cortical damage) as a consequence of multiple brain injuries. ARAT’s test-retest reliability (+0.98) was 
calculated with the Pearson product-moment correlation coefficient (r); a statistical measure useful for interval/ratio data29), 
and characterised by overestimation of the results due to its inability to indicate the proportion of agreement obtained by 
chance12, 30). The disease was not specified by Lyle and statistics were misused. Wagenaar et al.20) enhanced the consistency 
of the questionnaire, setting a time limit of 1 minute per task, to clarify scores 2 (takes abnormally long) and 3 (normal perfor-
mance). Another reliability study14), stated that Lyle’s protocol would be inadvisable and impracticable to therapists with less 
than five-years-experience. Yet, test-retest reliability was not considered and inter-rater reliability (+0.98) was estimated by 
three therapists with five years of experience. The intra-class correlation coefficient (ICC) was analysed considering the final 
score of both hands that implies a deterioration of the results due to a positive estimation ipsilateral to the lesion21). Platz et 
al.17) developed a standardised protocol identifying the test-retest (+0.96) of ARAT using a mixed small sample with different 
neurological deficits. Lin et al.24) reported test-retest (+0.99) reliability of ARAT using ICC in chronic stroke, however, they 
do not provide information on this type of reliability essential for appraising the evidence. Van der Lee et al.21) videotaped the 
sample measurements and utilised ICC, weighted kappas and Bland and Altman plots to report clinically significant results. 
Yozbatiran23) tested inter-rater (+0.99) and intra-rater (+0.99) reliability of the standardised protocol of ARAT in chronic 
stroke (n=12). However, this study set the chronic phase as 3 months after the onset, did not explain statistics, and changed 
the value for MCID (minimal clinically important difference) from −2.4 to +2.8 points. Above all, only three studies16, 17, 24) 
established test-retest reliability of ARAT in chronic stroke, but none of them stated to whom the protocol is referred.
The use of a video tape for analysis can enhance the accuracy of the assessment and minimise bias31–34). This project will 
use videotaped evidence of a chronic stroke patient performing ARAT, to determine whether PT’s ARAT scores are consistent 
over time. The following research question was formulated: Is ARAT consistent when the same physiotherapists use it over 
time to score upper limb function on a videotaped chronic stroke patient?
PARTICIPANTS AND METHODS
A convenience and snowball sampling of 20 PT (mean age=32 ± 6.8 years, mean experience=7.55 ± 7.4 years) scored a 
videotaped administration of ARAT performed by a chronic stroke patient. The COSMIN checklist35) provided guidance to 
the study design, ensuring that all the appropriate information required was reported to ease quality evaluation. The recruit-
ment was via emails and posters. Previous studies31–33) selected licenced PT with a minimum of one-year clinical experience 
to observe videotaped gait analysis and rate lower limb’s outcome measures in chronic stroke. Therefore, the present study 
included qualified PT with more than a year of clinical experience regardless of ethnicity that met one of the following 
criteria: (1) male/female; (2) staff-student members from Salford University; (3) volunteers; (4) specialist/senior or expert; 
and (5) PT with prior familiarisation with the tool. Prior to testing, information sheets and consent forms were given to the 
participants.
The measurements were performed in a familiar location and a minimum time interval of one week was defined sufficient 
regarding the retesting, as being performed by other studies17, 24, 31, 33), to minimise data recall from the first measurement and 
not cause maturation. Maturation refers to alternations within the indivisual factors that occur over time which may provide 
a non-consistent outcome to the later measurement36). The researcher(s) explained the scoring of ARAT to PT. The video was 
not paused during the observation to reflect a real time patient interaction. The participants (n=15) invited more PT (n=5) to 
increase the sample size using a non-probability technique of snowball sampling36, 37). “Intention to Treat” (ITT) was used 
for incomplete data38). The protocol received ethical approval from School Research Ethics, University of Salford, Salford, 
United Kingdom. The data collection occurred in May–June 2017.
The experimental (H1) and a null hypothesis (H0) are stated below:
• H1: If the same physiotherapists score the same videotaped performance of a chronic stroke patient twice using ARAT 
and their scores are similar, then results are due to consistency.
• H0: If the same physiotherapists score the same videotaped performance of a chronic stroke patient twice using ARAT 
and their scores are not related, then results are due to chance factors.
This is a 2-tailed hypothesis testing, since direction is not yet identified29, 37), and the level of statistical significance 
Alpha (a) value was set at 0.01. This study focuses on the stability of ARAT over time, so both direction and relationship 
among variables (time−ARAT scores) are being predicted naturally without manipulation29, 37). Due to the study’s correla-
tional design, there are no independent or dependent variables29). Extraneous variables such as situational variables (noise, 
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temperature, lighting degree, cleanliness, neatness, size of the room, convenience of the participants, an isolated room), 
personal variables (fatigue, mental health, bad/good mood, headaches and dizziness, intelligence and previous knowledge in 
neurology, anxiety, nerves, concertation, distraction, stress and bad visual acuity) and other variables (interpretation, balance 
in sound, duration of video, size of the screen quality of video and angle of the camera, surroundings, researcher’s attitude 
and personality) may have an impact on ARAT performance scores32, 37, 39, 40); however, not all of them were recorded during 
the study due to unforeseen circumstances. The ARAT subtests formulate scores in an ordinal set of data16–18).
The correlational study was analysed with the Spearman rank order correlation coefficient (rho)29) and the sum scores of 
each questionnaire were used to investigate the reliability as proposed by previous research15, 27). Non-parametric correlation 
tests are appropriate for ordinal data15, 29) and Spearman’s rank correlation coefficient measures the strength and direction of 
association between two variables (test, retest)29) using SPSS. The means and standard deviation (SD) were estimated from 
continuous variables (age, time, experience). However, a high correlation (rho) does not always represent good agreement 
between two repeated measurements30); thus, the line of equality was also utilised to illustrate visual agreement among the 
two methods (test against retest)31,37, 41) and the Bland and Altman plot30, 41, 42) that addresses the proportion of agreement 
between two clinical measurements (2 sets of data) and searches for possible outliers30). It must be noted that the mean 
difference (δ) is zero, since the same process has been used30, 41, 42). The Wilcoxon signed rank test was used for ordinal 
data to assess the mean rank scores (cases) and the statistical significance of differences between scores43), as in previous 
studies17, 19).
The video was displayed on two different screens. The time limit of 1 minute was set for the scores to be distinguishable20) 
and the mean difference between the two measurements was 16.6 days ± 4.9, ensuring independent administration of the tool. 
Lyle’s protocol16) was assigned to be scored by PT and no specific instructions were given. In actual clinical practice, a brief 
review and familiarisation with an instrument prior to its use is mandatory33); this was achieved by giving adequate time for 
the PT to familiarise themselves with the protocol. After the first session, PT was advised not to discuss, utilise, or further 
investigate the questionnaire until their final observation.
RESULTS
From the 20 sets of first data, 19 were collected after the second measurement. None of the PT had prior experience scor-
ing the ARAT. One of the participants dropped out of the study due to personal reasons. A statistical approach known as ITT 
analysis was found useful on this occasion, since it ignored withdrawals and non-compliance in this study38). The observed 
tasks were completed within the time limit. The international sample had a median of 5 years-experience as PT and a mean 
age of 32 years ± 6.8. Their demographics and origin are presented in Table 1 and Table 2 respectively. The reliability of 
the sum scores was calculated, and the value for the Spearman (rho) was found higher than 0.77 (Table 3), indicating good 
agreement between the measurements over time. The statistical significance p-value was determined as 0.00, which is small 
and less than the a-value, {p<a, (0.00<0.01)}, so the H0 was rejected and H1 is accepted.
Non-parametric correlations are shown in Table 3. Line of equality showed that the range of scores from 14.00 to 22.00. 
A non-parametric Wilcoxon signed rank test was conducted to evaluate whether a statistically significant difference existed 
between the mean ARAT scores of individuals that watched the video over time (H1). The value of mean scores on test (T1) 
was 17.4, while on retest (T2) decreased to 16.8, thus the mean change is 0.6 (small), suggesting that there are no statistically 
significant differences between them as shown in Table 3. Table 3 also indicates the ranks and there are seven cases where 
retest scores were lower than test (a), one case where retest was higher than test (b) and twelve which were the same (c). Table 
Table 1.  Demographics
Items Value
Age (years) 32 ± 6.81
Gender (male/female) 12/8
Years of experience (years) 7.55 ± 7.4
Test retest (days) 16.6 ± 4.9
Staff/students/other 3/14/3
Instrument calibration (times) 2
Duration of the video (min) 12
Size of the screen (inches) 14/120
Image quality (pixels) 1,920 × 1,080/1,280 × 720
During the study: bad visual acuity −anxiety =3
During the study: ARAT knowledge −neuroscience =4
Adverse events (headaches, dysphoria, dizziness) None
SD: standard deviation.
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3 shows a z-value of −2.154 associated with a p-value of 0.031, that is more than the a-value of 0.01 (p>a), so the H0 that 
there are no statistically significant differences between the scores of the sample is accepted. Coefficient of reproducibility 
(CR) is expressed as two times the difference of SD, CR=2 × SD and the 95% limits of agreement (LOA) are (δ=0) −1.96 
SD and (δ=0) + 1.96 SD30, 41, 42). CR=2SD (d2-d1)30)=(−1)2 +1+(2)2 +(1)2 +(1)2 +(4)2 +(3)2 +(1)2 ÷ N=34÷20=1.7 →CR=2 
×(√1.7) →CR=±2.6. The LOA are upper line (green): 1.96SD (+2.31) and lower line (red): −1.96SD (−2.31). The plot 
indicates two outliers from the LOA. A linear regression procedure was administrated to detect if there is any proportional 
bias, since there is a trend of points being above the mean difference. As can be seen in Table 3, the t-value (t=0.190) is linked 
with a statistical significance of p=0.851, greater than the a-value (0.01), so again H0 (null hypothesis) is accepted. Therefore, 
there is no proportional bias and there is a certain level of agreement between measurements.
DISCUSSION
The study investigated test-retest reliability of PT using ARAT in chronic stroke. Yozbatiran’s standardised instructions23) 
did not correspond to the videotape assessment, so Lyle’s decision rules16) in conjunction with the time limit of 1 minute20) 
were implemented. The correlation coefficient (rho) of ≈ 0.78 linked with a statistical significance of 0.00, shows that ARAT 
is a reliable, consistent, and reproducible OM when used by PT in chronic stroke. The line of equality showed a positive cor-
relation considering that the results lie along a line. However, relative reliability may give misleading results and a positive 
correlation is not necessarily related to good agreement30, 37, 41, 42). A previous study16) overestimated test-retest reliability, 
using Pearson correlation that applies to parametric data, without converting the non-parametric ARAT data. The statistically 
significant results contradict Hsieh’s findings14), which suggested that therapists with less than five years of experience are 
not consistent using ARAT. Our results are relatively consistent with previous findings24); the mean change of 0.6 points 
associated with a median of 16 days in this study is consistent with the mean change of 0.3 points and a median of 15 days 
Table 3.  Statistical Analysis (n=20)
1. Non-parametric correlations (Spearman’s rho)
Test Retest p value
1.000 0.775 0.000*
2. Descriptive statistics (mean ± SD)
Test Retest
17.4 ± 1.9 16.8 ± 1.85
3. Wilcoxon Signed Rank (Ranks)
Number Mean Rank Sum of Ranks
Negative ranks 7a 4.71 33
Positive ranks 1b 3 3
Ties 12c - -
Total 20 - -
Z value 
(retest−test)
−2.15¥
p value 0.031
4. Coefficients
Unstandardized Standardized
t value p value
B Std. error Beta
Constant 0.09 2.7 - 0.033 0.97
Mean 0.03 0.16 0.045 0.19 0.85
*p<0.05; aretest<test; bretest>test; cretest=test; ¥based on positive ranks.
Table 2.  Ethnicity and potential threats to internal validity
County
Number of 
participants  Location of test PT
Major factors that may have an impact 
on ARAT performance scores
United Kingdom 3 Familiar 2 Staff Attentiveness-instrumentation 
Saudi Arabia 7 Familiar Students Fatigue −motivation −drop out
Nigeria 1 Familiar Student Visual acuity −fatigue
India 1 Familiar Student
Brazil 4 2 not familiar 1 Staff Motivation
Greece 4 1 not familiar 1 Student Viewing distance
PT: physiotherapist; ARAT: action research arm test.
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found by van der Lee44). CR is not mentioned in their study44), the mean difference (δ) is not considered 0 in plots, as usual 
for repeated measurements30), and LOA (−5.7, +6.2) were greater than the MCID. The Wilcoxon signed rank test was used 
to analyse descriptive statistics and mean rank scores. Lin24) targeted the examiners for ARAT without defining terms such 
as ‘specially trained PT’, thus Lin’s24) sample is not representative and their results cannot be generalised due to sampling 
error. To the best of our knowledge, none of the previous studies16–18, 21, 23, 24, 44) considered Bland and Altman plots and CR 
to estimate ARAT’s test-retest reliability.
PT with multiple nationalities were involved and either a laptop or a projector was utilised to play the videotape in each 
case accordingly. Situational variables were controlled; measurements being performed late morning provided an adequate 
degree of lighting, while the rooms for PT were clean, quiet and ensured a comfortable temperature to avoid distraction and 
injuries45). The individuals were observed naturally and examined verbally for their health (headaches, injury, convenience) 
and well-being (stress, thoughts, feelings). Natural observation refers to the process when the researcher joins the group to 
obtain a deeper understanding of PT46). Fatigue and distance from the display are two of the personal variables not recorded 
that may have influenced the outcome of the study; 8 PT that scored the protocol twice were Muslims and measurements were 
conducted during Ramadan. Fasting is directly linked with fatigue and headaches47), however, none of the PT complained 
about headaches. Three PT (1 Greek, 2 Brazilian) that scored the protocol were not familiar with the environment. The mean 
difference was 16.6 ± 4.9 (days) when the measurements performed, with a range of days (7–24). More than one week was 
highlighted by previous studies33) to reduce the potential for memory effects. Although, standardisation regarding maturation 
of a sample has not been yet identified and it basically depends on the nature of research48). Most PT that participated in 
the study were students and staff members, so knowledge acquisition may comprise a factor of maturation, particularly in 
longer term changes48). However, the mean difference of 16.6 days among the two measurements was within the time period 
suggested by previous studies33, 49). Motivation, reward, and interest are three extraneous variables that may have influenced 
the scoring procedure and were not assessed during the study.
Considering potential threats to internal validity, instrumentation and history may influence the findings of a study48). 
On this occasion, instrumentation occurs when the device used alters over time, so instrumental bias may have affected the 
results. In total, 39 observations were performed (1 drop out): 16 observations in which the video was played through a 
14-inch laptop and 18 observations via a 120-inch projector, matched for both test-retest. The device provided was changed 
from projector to laptop for 4 of the observations regarding retesting. While Neuman50) suggests that larger screens with a 
poor-quality image may provide a greater sense of presence, enjoyment, and intense responses, Lombard51) gives more value 
to smaller displays with high resolution. Consequently, stability and balance within electronic devices were verified in this 
study and instrumentation was not a limiting factor.
Chanubol et al.19) defined a classification scale to track the severity of arm impairment based on ARAT, with a score less 
than 10 determined severe. Using Chanubols’ classification system in conjunction with the range of scores (14−22) and the 
mean scores of 16.8 and 17.4 respectively, the present study categorises patient’s arm impairment as moderate. This was 
confirmed by Nijland et al.52), who compared the Wolf Motor Function Test (WMFT) with ARAT and recommended the 
protocol for patients with moderate hemiparesis, while van der Lee et al.22) stated that ARAT may not be sensitive enough 
to identify change in chronic stroke patients approaching severe or normal arm function. International guidelines27) and 
previous studies22, 24, 52) demonstrated that ARAT has notable floor and ceiling effects when capturing changes in severe or 
mild stroke patients. Floor and ceiling effects of ARAT are calculated as 5% of the scale, and to be identified, 20% of the total 
scores need to be appointed above or below the LOA. Bland and Altman plot showed two outliers, so there are no significant 
floor and ceiling effects in this study and the patient is likely to have moderate impairment52), in agreement with Chanubol 
et al.19), but if the patient had severe or near normal UL impairment, this study would have given robust evidence regarding 
floor and ceiling effects. This study did not confirm the patient’s non-affected side.
Interestingly, the resulting value of CR=± 2.6 points approaches numerically the LOA (± 2.3) in this study, confirming 
that these two values are statistically related to each other, as proposed by other studies53, 54). It must be noted that CR does 
not represent the MCID55), and clinicians remain subjective while estimating CR, since many studies proposed the equation 
differently30, 41, 42, 53). CR is a psychometric property of ARAT which reflects the instrument’s ability to capture a difference 
of  ± 2.6 points, while MCID is the selected minimal value, previously set by clinicians to determine whether the outcome 
has been clinically significant due to intervention53, 55). The value of CR=± 2.6 in this study is less than the MCID=5.7 points 
of ARAT (10% of the scale)21) (CR<MCID), verifying that ARAT is a valid outcome measure that accurately identifies real 
change. Consequently, responsiveness and reproducibility are directly connected to each other53, 54). Since a trend being 
above the mean difference was detected, a linear regression was completed to search for proportional bias. Bland and Alt-
man plot identifies two outliers likely due to the variability of the measurement. One of the outliers had bad visual acuity 
(confounding variable). No proportional bias was found and the LOA (± 2.3) was less than the MCID of 5.7 points, so ARAT 
is capable of detecting clinically relevant changes.
However, the findings in this study must be interpreted with caution. Using a videotape for analysis automatically reduces 
measurement variability, eliminating the need for the patient to perform the ARAT multiple times that may cause fatigue33). 
Non-probability sampling is vulnerable to selection bias, the PT were not blinded to the video, but the allowed time interval 
was considered adequate for both data memorisation and sample maturation. Despite the robust statistical methods used, 
the small a-value (0.01) increased the confidence for significant results. Three researchers with previous experience scored 
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the ARAT, which may lead to biased results, and captured only the affected side of the patient. Another potential limitation 
may be instrumentation. The results would have yielded a more precise estimation of reliability if the two outliers have 
been excluded. Assuming this sample with a mean age of 32 ± 6.81 years and a mean experience of 7.55 ± 7.4 years to be 
representative of the whole population, then the results can be generalised to a wider population. Despite these limitations, 
the findings of this study suggest that PT should use the ARAT for the examination of UL function in moderate chronic stroke.
The ARAT demonstrates good test-retest reliability using statistical analysis with Spearman’s rank order correlation coef-
ficient, Bland and Altman plots and linear regression. These results illustrate good test-retest and are consistent. The included 
sample accurately reflects a larger population with a mean age of 32  ± 7 years, mean experience of 7.55 ± 7.4 years and 
six different nationalities. Therefore, the results are representative internationally, and PT should use and score the protocol. 
However, the reported results should be interpreted with caution due to the small sample size and the selected type of 
sampling.
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